Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential Hypertension

NCT07064525 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

252

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension (HTN)
NYHA Class III Heart Failure
NYHA Class IV Heart Failure
Diabete Mellitus

Interventions

DRUG: SPC1001 Low
DRUG: SPC5002
DRUG: SPC5003
DRUG: SPC5004

Sponsor

Shin Poong Pharmaceutical Co. Ltd.